Kevin McLaughlin discusses how one survivor's faith in science underscores the importance of continued funding for cancer research.
by Kevin McLaughlin
Keeping Hope Alive | Taking a Shot at Cervical Cancer | Lung Cancer Screening for Smokers Almost Ready for Prime Time | Truth in Advertising | Coming Up Short | Striking a Nerve
Your Cancer Guide
With planning, most patients and survivors can experience the rejuvenation that comes with getting away.
by Hester Hill Schnipper
Help your loved one conquer the mountain of medical and financial information that cancer brings on.
by Michelle Johnston-Fleece
Asking the right questions can help patients living with metastatic cancer understand the risks and benefits of recommended treatments and formulate their goals more effectively.
by Charlotte Huff
As cancer survivor numbers grow and longevity increases, researchers study how to ease symptoms and side effects.
by Melissa Weber
Diagnosed with a rare and incurable blood cancer, Jack Whelan is a passionate booster for research, clinical trials and affordable treatments.
by Betty Russell
The informed consent process is designed to ensure that patients understand risks. But new advances involved in genetic testing and tissue donation may make signing on the dotted line more complex than ever.
by Stephen Ornes
Yesterday & Today
Whether it was a star turn playing Blanche DuBois or Daisy Werthan, Jessica Tandy sparkled in a tough role. That didn't change after her cancer diagnosis.
by Karen Patterson
Keep It Simple | The Right Routine
Patient advocate Ivis Febus-Sampayo promotes support services for cancer patients in minority communities.
by Marci A. Landsmann
On weighing acupuncture for cancer-related symptoms, getting help while caring for a parent, and having pets during treatment.
Joan A. Smith organizes volunteers’ efforts to send cards to cancer patients.
by Maria Wolf
Oscar Llerena, Kimberlee Eshbaugh, Julie Garrabrant.
Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.
by Ashley P. Taylor
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.
Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.
In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.
Learning Medicare’s ABCDs
donate to the AACR